Small Molecule Targeting KSHV Lytic Genes for Tumor Suppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for tumors caused by tumor viruses, such as Kaposi sarcoma-associated herpesvirus (KSHV), are ineffective in suppressing viral gene expression and tumor progression, leading to challenging therapeutic outcomes for malignant lymphomas like primary effusion lymphoma.
Innovation Solution
A pharmaceutical composition containing a low-molecular-weight compound that targets and suppresses the expression of gene products involved in the lytic cycle of tumor viruses, specifically KSHV, thereby inhibiting viral replication and tumor growth, exemplified by N-[5-fluoro-2-(1-piperidinyl)phenyl]-4-pyridinethioamide.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used for tumors caused by tumor viruses, then the treatment approach is simple, but the effectiveness in suppressing viral gene expression and tumor progression is insufficient
Solution Approach 1:
The patent introduces a small molecule compound as an intermediary substance that mediates between the host cell and the tumor virus. This compound specifically targets and suppresses viral gene expression by interacting with viral proteins or host factors, thereby enhancing treatment effectiveness without requiring complex combination therapies or genetic modifications.
2Object-affected harmful factors
If a component targeting tumor virus gene product is used, then antiviral effect is enhanced, but the complexity of the pharmaceutical composition increases
Solution Approach 1:
The patent utilizes small molecule compounds that can be precisely controlled in terms of molecular structure, concentration, and pharmacokinetic parameters. By optimizing these parameters, the compound achieves high antiviral efficacy against KSHV while maintaining a relatively simple pharmaceutical composition formulation compared to biologics or complex delivery systems.
Data Source
AI summary
Provided is a method for preventing, ameliorating, suppressing the progression of, and/or treating a tumor caused by a tumor virus, the method including the step of administering, to a subject, an effective amount of a component that targets a gene product of the tumor virus.